Public-academic partnerships: a program to improve the quality of antipsychotic prescribing in a community mental health system.
Mary F. Brunette,Alexander de Nesnera,Karin Swain,Erik G. Riera,Doris Lotz,Stephen J. Bartels +5 more
TLDR
A public-academic partnership in New Hampshire and a quality improvement program it carried out encourages providers at community mental health centers to adopt prescribing practices that limit the cardiometabolic side effects of antipsychotic medicines.Abstract:
State mental health authorities can use public-academic partnerships to create professional roles in which leaders can track trends, identify problems, and carry out quality improvement projects to address key issues. Leaders with positions in both academic institutions and state mental health authorities ensure access to resources, technical expertise, and key relationships to improve quality. The authors describe a public-academic partnership in New Hampshire and a quality improvement program it carried out. The program encourages providers at community mental health centers to adopt prescribing practices that limit the cardiometabolic side effects of antipsychotic medicines. (Psychiatric Services 62:1004–1006, 2011)read more
Citations
More filters
Journal ArticleDOI
Use of Academic Detailing With Audit and Feedback to Improve Antipsychotic Pharmacotherapy.
Mary F Brunette,Robert O. Cotes,Alexander de Nesnera,Gregory McHugo,Nino Dzebisashvili,Haiyi Xie,Stephen J. Bartels +6 more
TL;DR: Polypharmacy decreased among young and older adults after academic detailing with audit and feedback, and this low-intensity intervention may help mental health systems reduce antipsychotic polyphARMacy.
Journal ArticleDOI
Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US Adults
Marcela Horvitz-Lennon,Rita Volya,Katya Zelevinsky,Mimi Shen,Julie M. Donohue,Andrew W. Mulcahy,Sharon-Lise T. Normand +6 more
TL;DR: In this article, the authors assessed APP prevalence and APP association with beneficiary race/ethnicity and payer among publicly-insured adults regardless of diagnosis, and found that 11% to 21% of 397,533 antipsychotic users and 12% to 19% of 9,396,741 person-months had some APP utilization.
References
More filters
Journal ArticleDOI
Continuing education meetings and workshops: effects on professional practice and health care outcomes
Louise Forsetlund,Arild Bjørndal,Arash Rashidian,Gro Jamtvedt,Mary Ann O’Brien,Fredric M. Wolf,Dave Davis,Jan Odgaard-Jensen,Andrew D Oxman +8 more
TL;DR: Educational meetings alone or combined with other interventions, can improve professional practice and healthcare outcomes for the patients and is most likely to be small and similar to other types of continuing medical education, such as audit and feedback, and educational outreach visits.
Journal ArticleDOI
Principles of educational outreach ('academic detailing') to improve clinical decision making.
Stephen B. Soumerai,Jerry Avorn +1 more
TL;DR: Using the theory and practice of methods to improve physicians' clinical decision making to enhance the quality and cost-effectiveness of care and to reduce inappropriate prescribing as well as unnecessary health care expenditures are shown.
Journal ArticleDOI
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Robert W. Buchanan,Julie Kreyenbuhl,Julie Kreyenbuhl,Deanna L. Kelly,Jason M. Noel,Douglas L. Boggs,Bernard A. Fischer,Seth Himelhoch,Beverly Fang,Eunice Peterson,Patrick R. Aquino,William R. Keller +11 more
TL;DR: An extensive literature review was conducted to determine whether the current psychopharmacological treatment recommendations required revision and whether there was sufficient evidence to warrant new treatment recommendations for prespecified outcomes of interest.
Journal ArticleDOI
Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
Elaine H. Morrato,Benjamin G. Druss,Daniel M. Hartung,Robert J. Valuck,Richard P. Allen,Elizabeth J. Campagna,John W. Newcomer +6 more
TL;DR: In a Medicaid-receiving population, baseline glucose and lipid testing for SGA-treated patients was infrequent and showed little change following the diabetes warning and monitoring recommendations, and a change in SGA drug selection consistent with intentions to reduce metabolic risk was observed.
Journal ArticleDOI
Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.
Stephen B. Soumerai,Fang Zhang,Dennis Ross-Degnan,Daniel E. Ball,Robert F. LeCates,Michael R. Law,Tom E. Hughes,Daniel Chapman,Alyce S. Adams +8 more
TL;DR: More than one-third of Medicaid programs and Medicare Part D plans use prior authorization (PA) policies to control the use of atypical antipsychotics (AAs).
Related Papers (5)
Providing integrated mental health services: a policy and management perspective
Tom Callaly,Anna Fletcher +1 more